CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-18 | Quisel John D Chief Executive Officer | Sale | −5,574 | $54.58 | $304K | 154,828 |
| 2025-02-10 | Stephenson Pamela Chief Commercial Officer | Grant or award | +36,000 | 72,666 | ||
| 2025-02-10 | Stephenson Pamela Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2025-02-10 | Khara Rahul Chief Legal Officer | Grant or award | +24,000 | 38,035 | ||
| 2025-02-10 | Khara Rahul Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2025-02-10 | Yu Jonathan Yen-Wen Chief Operating Officer | Grant or award | +24,000 | 42,165 | ||
| 2025-02-10 | Yu Jonathan Yen-Wen Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2025-02-10 | Franchi Jean M. Chief Financial Officer | Grant or award | +36,000 | 72,666 | ||
| 2025-02-10 | Franchi Jean M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2025-02-10 | Quisel John D Chief Executive Officer | Grant or award | +78,337 | 160,402 | ||
| 2025-02-10 | Quisel John D Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +117,505 | 117,505 | ||
| 2025-02-10 | Savage William Jacob Chief Medical Officer | Grant or award | +24,000 | 70,136 | ||
| 2025-02-10 | Savage William Jacob Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2025-02-03 | Savage William Jacob Chief Medical Officer | Option exercise | +4,233 | $2.65 | $11K | 44,638 |
| 2025-02-03 | Savage William Jacob Chief Medical Officer | Option exercise | +1,498 | $2.65 | $4K | 46,136 |
| 2025-02-03 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,233 | 0 | ||
| 2025-02-03 | Savage William Jacob Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −1,498 | 0 | ||
| 2025-02-03 | Khara Rahul Chief Legal Officer | Option exercise 10b5-1 | +7,500 | $14.69 | $110K | 21,535 |
| 2025-02-03 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −5,687 | $55.40 | $315K | 15,848 |
| 2025-02-03 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −1,813 | $56.01 | $102K | 14,035 |
Page 16 of 17 · 337 trades